I agree. But there is no market for Viradx. Smart companies who actually sell a Covid/Flu test are pulling back:
Abbott anticipated the drop and pulled back manufacturing of its PANBIO Cov/Flu. They cited a drop in related testing (worldwide) from $3.3 Billion in US Q1 2022 all the way down to $700 Million last Quarter. But they're smart and announced they are moving toward climate change related virus testing and other initiatives. Their diagnostic sales are down 20%, but if you exclude Covid/Flu testing, they are actually UP.
Thermo announced it stopped producing it's Point of Care Rapid PCR based Covid Flu tests and is running out it's inventory.
LDX Price at posting:
2.3¢ Sentiment: None Disclosure: Held
